The Trump plan would connect some drug prices to what peer nations pay

May 12th update: Read more about the Executive order and what it means here.

President Trump will sign an executive order on Monday that aims to reduce some drug prices in the United States by organizing them with the other wealthy countries, he said on Sunday evening about the social of truth.

The proposal he described, which alone cannot change federal politics, is what he describes as the “most preferred nation” price model. Mr. Trump did not give any details about which type of insurance the plan for or how many drugs would address, but he indicated that the United States should pay the lowest price among the peer countries.

“Our country is finally treated fairly, and the health costs of the citizens are reduced by numbers that have never been thought before,” he wrote in his social media post.

Such a plan will most likely be subject to a challenge in court, and it is not clear whether it will be passed on legal patterns, especially without measures of the congress.

During his first term, Mr. Trump unsuccessfully tried to create a version of this idea for Medicare, the health insurance program that covers 68 million Americans who are over 65 or have disabilities. This plan would only have applied for 50 medication that were administered in clinics and hospitals and are paid by Medicare. A federal court blocked it and decided that the government had skipped steps in the political decision -making process.

The pharmaceutical industry bitterly rejects the idea that would quite certainly reduce its profit and campaign against it, since the discussion about politics in Washington has been regained in the past few weeks. Companies have warned that such a policy would make them spend less for research and to deprive patients with new medication.